| BP0273-100MG
| InVivoPlus anti-mouse PD-1 (CD279)
| 100 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling, in vitro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0131-50MG
| InVivoPlus anti-mouse CTLA-4 (CD152)
| 50 mg
| BioXCell
| in vivo CTLA-4 neutralization, in vitro CTLA-4 neu
|
| Syrian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0241-100MG
| InVivoPlus anti-mouse IFNAR-1
| 100 mg
| BioXCell
| in vivo IFNAR-1 blockade, in vitro IFNAR-1 blockad
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0301-100MG
| InVivoPlus human IgG2 isotype control
| 100 mg
| BioXCell
|
|
| Human
| n/
| Solicitar Precio
| Solicitar
|
| BP0283-100MG
| InVivoPlus anti-human/mouse/rat CD47
| 100 mg
| BioXCell
| in vivo CD47 blockade, in vitro CD47 blockade, Imm
|
| Mouse
| human/mouse/rat
| Solicitar Precio
| Solicitar
|
| BP0131-5MG
| InVivoPlus anti-mouse CTLA-4 (CD152)
| 5 mg
| BioXCell
| in vivo CTLA-4 neutralization, in vitro CTLA-4 neu
|
| Syrian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0169-50MG
| InVivoPlus anti-mouse 4-1BB (CD137)
| 50 mg
| BioXCell
| in vivo activation of 4-1BB
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0146-100MG
| InVivoPlus anti-mouse PD-1 (CD279)
| 100 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0117-5MG
| InVivoPlus anti-mouse CD8?
| 5 mg
| BioXCell
| in vivo CD8+ T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0164-100MG
| InVivoPlus anti-mouse CTLA-4 (CD152)
| 100 mg
| BioXCell
| in vivo CTLA-4 neutralization
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0290-5MG
| InVivoPlus rat IgG1 isotype control
| 5 mg
| BioXCell
|
|
| Rat
| n/
| Solicitar Precio
| Solicitar
|
| BP0301-50MG
| InVivoPlus human IgG2 isotype control
| 50 mg
| BioXCell
|
|
| Human
| n/
| Solicitar Precio
| Solicitar
|
| BP0290-100MG
| InVivoPlus rat IgG1 isotype control
| 100 mg
| BioXCell
|
|
| Rat
| n/
| Solicitar Precio
| Solicitar
|
| BP0241-50MG
| InVivoPlus anti-mouse IFNAR-1
| 50 mg
| BioXCell
| in vivo IFNAR-1 blockade, in vitro IFNAR-1 blockad
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0099-25MG
| InVivoPlus recombinant CTLA-4-Ig (hum./hum.)
| 25 mg
| BioXCell
|
|
| n/a
| n/
| Solicitar Precio
| Solicitar
|
| BP0301-5MG
| InVivoPlus human IgG2 isotype control
| 5 mg
| BioXCell
|
|
| Human
| n/
| Solicitar Precio
| Solicitar
|
| BP0088-25MG
| InVivoPlus rat IgG1 isotype control (anti-HRP)
| 25 mg
| BioXCell
|
|
| Rat
| n/
| Solicitar Precio
| Solicitar
|
| BP0273-25MG
| InVivoPlus anti-mouse PD-1 (CD279)
| 25 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling, in vitro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0239-5MG
| InVivoPlus anti-mouse CD137 (4-1BB)
| 5 mg
| BioXCell
| in vivo 4-1BB stimulation, in vitro 4-1BB stimulat
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0273-5MG
| InVivoPlus anti-mouse PD-1 (CD279)
| 5 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling, in vitro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0213-25MG
| InVivoPlus anti-mouse CSF1R (CD115)
| 25 mg
| BioXCell
| in vivo macrophage depletion, in vitro CSF-R1 neut
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0088-5MG
| InVivoPlus rat IgG1 isotype control (anti-HRP)
| 5 mg
| BioXCell
|
|
| Rat
| n/
| Solicitar Precio
| Solicitar
|
| BP0283-50MG
| InVivoPlus anti-human/mouse/rat CD47
| 50 mg
| BioXCell
| in vivo CD47 blockade, in vitro CD47 blockade, Imm
|
| Mouse
| human/mouse/rat
| Solicitar Precio
| Solicitar
|
| BP0083-100MG
| InVivoPlus mouse IgG1 isotype control
| 100 mg
| BioXCell
|
|
| Mouse
| n/
| Solicitar Precio
| Solicitar
|
| BP0131-100MG
| InVivoPlus anti-mouse CTLA-4 (CD152)
| 100 mg
| BioXCell
| in vivo CTLA-4 neutralization, in vitro CTLA-4 neu
|
| Syrian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0033-2-100MG
| InVivoPlus anti-mouse PD-1 (CD279)
| 100 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling, in vitro
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0115-25MG
| InVivoPlus anti-mouse TIM-3 (CD366)
| 25 mg
| BioXCell
| in vivo TIM-3 neutralization, in vitro TIM-3 block
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0089-25MG
| InVivoPlus rat IgG2a isotype control
| 25 mg
| BioXCell
|
|
| Rat
| n/
| Solicitar Precio
| Solicitar
|
| BP0174-50MG
| InVivoPlus anti-mouse LAG-3
| 50 mg
| BioXCell
| in vivo LAG-3 neutralization, in vitro LAG-3 neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0310-100MG
| InVivoPlus anti-mouse VISTA
| 100 mg
| BioXCell
| in vivo blocking of VISTA signaling, in vitro bloc
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0239-100MG
| InVivoPlus anti-mouse CD137 (4-1BB)
| 100 mg
| BioXCell
| in vivo 4-1BB stimulation, in vitro 4-1BB stimulat
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0099-50MG
| InVivoPlus recombinant CTLA-4-Ig (hum./hum.)
| 50 mg
| BioXCell
|
|
| n/a
| n/
| Solicitar Precio
| Solicitar
|
| BP0117-25MG
| InVivoPlus anti-mouse CD8?
| 25 mg
| BioXCell
| in vivo CD8+ T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0283-5MG
| InVivoPlus anti-human/mouse/rat CD47
| 5 mg
| BioXCell
| in vivo CD47 blockade, in vitro CD47 blockade, Imm
|
| Mouse
| human/mouse/rat
| Solicitar Precio
| Solicitar
|
| BP0297-100MG
| InVivoPlus human IgG1 isotype control
| 100 mg
| BioXCell
|
|
| Human
| n/
| Solicitar Precio
| Solicitar
|
| BP0297-25MG
| InVivoPlus human IgG1 isotype control
| 25 mg
| BioXCell
|
|
| Human
| n/
| Solicitar Precio
| Solicitar
|
| BP0090-100MG
| InVivoPlus rat IgG2b I sotype control
| 100 mg
| BioXCell
|
|
| Rat
| n/
| Solicitar Precio
| Solicitar
|
| BP0164-50MG
| InVivoPlus anti-mouse CTLA-4 (CD152)
| 50 mg
| BioXCell
| in vivo CTLA-4 neutralization
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0273-50MG
| InVivoPlus anti-mouse PD-1 (CD279)
| 50 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling, in vitro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0297-50MG
| InVivoPlus human IgG1 isotype control
| 50 mg
| BioXCell
|
|
| Human
| n/
| Solicitar Precio
| Solicitar
|
| BP0089-50MG
| InVivoPlus rat IgG2a isotype control
| 50 mg
| BioXCell
|
|
| Rat
| n/
| Solicitar Precio
| Solicitar
|
| BP0174-5MG
| InVivoPlus anti-mouse LAG-3
| 5 mg
| BioXCell
| in vivo LAG-3 neutralization, in vitro LAG-3 neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0086-25MG
| InVivoPlus mouse IgG2b isotype control
| 25 mg
| BioXCell
|
|
| Mouse
| n/
| Solicitar Precio
| Solicitar
|
| BP0083-50MG
| InVivoPlus mouse IgG1 isotype control
| 50 mg
| BioXCell
|
|
| Mouse
| n/
| Solicitar Precio
| Solicitar
|
| BP0085-5MG
| InVivoPlus mouse IgG2a isotype control
| 5 mg
| BioXCell
|
|
| Mouse
| n/
| Solicitar Precio
| Solicitar
|
| BP0091-5MG
| InVivoPlus polyclonal Armenian hamster IgG
| 5 mg
| BioXCell
|
|
| Armenian hamster
| n/
| Solicitar Precio
| Solicitar
|
| BP0087-25MG
| InVivoPlus polyclonal Syrian hamster IgG
| 25 mg
| BioXCell
|
|
| Syrian hamster
| n/
| Solicitar Precio
| Solicitar
|
| BP0297-5MG
| InVivoPlus human IgG1 isotype control
| 5 mg
| BioXCell
|
|
| Human
| n/
| Solicitar Precio
| Solicitar
|
| BP0117-100MG
| InVivoPlus anti-mouse CD8?
| 100 mg
| BioXCell
| in vivo CD8+ T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0164-5MG
| InVivoPlus anti-mouse CTLA-4 (CD152)
| 5 mg
| BioXCell
| in vivo CTLA-4 neutralization
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|